Rapamycin ameliorates the CTLA4-Ig-mediated defect in CD8(+) T cell immunity during gammaherpesvirus infection.

MLA

Pinelli, D. F., et al. “Rapamycin Ameliorates the CTLA4-Ig-Mediated Defect in CD8(+) T Cell Immunity during Gammaherpesvirus Infection.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 15, no. 10, Oct. 2015, pp. 2576–87. EBSCOhost, https://doi.org/10.1111/ajt.13326.

APA

Pinelli, D. F., Wakeman, B. S., Wagener, M. E., Speck, S. H., & Ford, M. L. (2015). Rapamycin ameliorates the CTLA4-Ig-mediated defect in CD8(+) T cell immunity during gammaherpesvirus infection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15(10), 2576–2587. https://doi.org/10.1111/ajt.13326

Chicago

Pinelli, D F, B S Wakeman, M E Wagener, S H Speck, and M L Ford. 2015. “Rapamycin Ameliorates the CTLA4-Ig-Mediated Defect in CD8(+) T Cell Immunity during Gammaherpesvirus Infection.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15 (10): 2576–87. doi:10.1111/ajt.13326.